{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:21:55Z","timestamp":1785896515590,"version":"3.56.0"},"reference-count":13,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"abstract":"<jats:p>Neonatal seizures represent a significant health burden on the term and preterm neonatal population and are linked to poor long-term neurodevelopmental outcomes. Currently, there are no US Food and Drug Administration\u2013approved antiepileptic drugs for neonates, and authors of the medical literature have yet to reach a consensus on the most adequate approach to neonatal seizures. Topiramate is readily used in the adult and older pediatric population for the management of migraines and partial-onset seizures. Topiramate continues to gain favor among pediatric neurologists who often recommend this medication as a third-line treatment of neonatal seizures. We report our recent experience with 4 preterm neonates, born between 2015 and 2017, who developed radiographic signs of necrotizing enterocolitis after receiving topiramate for seizures. Each was given oral topiramate for the treatment of electrographic and clinical seizures and developed the subsequent diagnosis of necrotizing enterocolitis, with abdominal distention, hemoccult-positive stools, and radiographic signs of intestinal distention and pneumatosis. More research regarding the risk factors of topiramate use in premature infants is needed.<\/jats:p>","DOI":"10.1542\/peds.2017-3971","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T10:05:15Z","timestamp":1528970715000},"source":"Crossref","is-referenced-by-count":15,"title":["Topiramate for Seizures in Preterm Infants and the Development of Necrotizing Enterocolitis"],"prefix":"10.1542","volume":"142","author":[{"given":"Benjamin","family":"Courchia","sequence":"first","affiliation":[{"name":"Divisions of Neonatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Kurtom","sequence":"additional","affiliation":[{"name":"Divisions of Neonatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Pensirikul","sequence":"additional","affiliation":[{"name":"Pediatric Neurology, Department of Pediatrics, Miller School of Medicine, University of Miami and Jackson Memorial Hospital, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Del-Moral","sequence":"additional","affiliation":[{"name":"Divisions of Neonatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Buch","sequence":"additional","affiliation":[{"name":"Divisions of Neonatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2018,7,1]]},"reference":[{"issue":"1","key":"2021121103265581800_B1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.jp.7200107","article-title":"Neonatal seizures: incidence, onset, and etiology by gestational age.","volume":"19","author":"Sheth","year":"1999","journal-title":"J Perinatol"},{"issue":"23","key":"2021121103265581800_B2","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1212\/01.wnl.0000295674.34193.9e","article-title":"Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome.","volume":"69","author":"Pisani","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"2021121103265581800_B3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.siny.2013.04.005","article-title":"Newly emerging therapies for neonatal seizures.","volume":"18","author":"Pressler","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"issue":"11","key":"2021121103265581800_B4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/jp.2013.116","article-title":"Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures.","volume":"33","author":"Maitre","year":"2013","journal-title":"J Perinatol"},{"issue":"2","key":"2021121103265581800_B5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2008.04.008","article-title":"Off-label use of antiepileptic drugs for the treatment of neonatal seizures.","volume":"39","author":"Silverstein","year":"2008","journal-title":"Pediatr Neurol"},{"issue":"4","key":"2021121103265581800_B6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.yebeh.2005.03.001","article-title":"Effect of topiramate on cognitive function and activity level following neonatal seizures.","volume":"6","author":"Zhao","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"6","key":"2021121103265581800_B7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2011.01.006","article-title":"Topiramate for the treatment of neonatal seizures.","volume":"44","author":"Glass","year":"2011","journal-title":"Pediatr Neurol"},{"issue":"3","key":"2021121103265581800_B8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jpeds.2010.04.019","article-title":"Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study.","volume":"157","author":"Filippi","year":"2010","journal-title":"J Pediatr"},{"issue":"3","key":"2021121103265581800_B9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2008-0642","article-title":"Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.","volume":"123","author":"Lewis","year":"2009","journal-title":"Pediatrics"},{"issue":"10","key":"2021121103265581800_B10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1526-4610.2005.00262.x","article-title":"Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.","volume":"45","author":"Winner","year":"2005","journal-title":"Headache"},{"issue":"6","key":"2021121103265581800_B11","first-page":"347","article-title":"Drug consumption and additional risk factors associated with microscopic colitis: case-control study.","volume":"107","author":"Guagnozzi","year":"2015","journal-title":"Rev Esp Enferm Dig"},{"issue":"2B","key":"2021121103265581800_B12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1590\/S0004-282X2005000300032","article-title":"Topiramate and severe metabolic acidosis: case report.","volume":"63","author":"Burmeister","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"2021121103265581800_B13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1017\/S0012162201001268","article-title":"Topiramate-induced metabolic acidosis: report of two cases.","volume":"43","author":"Ko","year":"2001","journal-title":"Dev Med Child Neurol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-3971\/1065152\/peds_20173971.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-3971\/1065152\/peds_20173971.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T08:45:14Z","timestamp":1639212314000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/142\/1\/e20173971\/37488\/Topiramate-for-Seizures-in-Preterm-Infants-and-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,7,1]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2017-3971","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,1]]},"article-number":"e20173971"}}